ClinicalTrials.gov
ClinicalTrials.gov Menu

Frequency of Accessing Central Lines for Blood Samples

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00366314
Recruitment Status : Terminated
First Posted : August 21, 2006
Last Update Posted : June 13, 2007
Sponsor:
Information provided by:
Children's Healthcare of Atlanta

Brief Summary:

The purpose of this study is to quantify and analyze the line accesses for each of the 3 participating ICUs.

The hypothesis is that the CICU will have a significantly higher number of line accesses than the other units. Analyzing the data will assist the researchers in identifying best practices and ultimately, reduce the BSI rate in the CICU.


Condition or disease
Congenital Disorders

  Show Detailed Description

Study Type : Observational
Enrollment : 320 participants
Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Retrospective
Official Title: Frequency of Accessing Central Lines for Blood Samples and Medication Administration: A Comparison Between CICU, PICU and NICU
Study Start Date : June 2003




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • ICUs at Egleston Hospital, Children's Healthcare of Atlanta
  • June 1, 2003 - June 30, 2006
  • ICU LOS between 14 and 28 days
  • Central access
  • 30 days to 18 years

Exclusion Criteria:

  • Those who do not meet inclusion criteria

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00366314


Locations
United States, Georgia
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322
Sponsors and Collaborators
Children's Healthcare of Atlanta
Investigators
Principal Investigator: Nicole M Jarrell, RNC, MSN Children's Healthcare of Atlanta

ClinicalTrials.gov Identifier: NCT00366314     History of Changes
Other Study ID Numbers: 06-142
First Posted: August 21, 2006    Key Record Dates
Last Update Posted: June 13, 2007
Last Verified: June 2007

Keywords provided by Children's Healthcare of Atlanta:
Blood samples
Medication administration
CICU
PICU
NICU